查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599242

兽用感染疾病物市场：按动物类型、产品类型、给药途径和分销管道分类 - 2025-2030 年全球预测

Veterinary Anti-infectives Market by Animal Type (Companion Animal, Livestock), Product Type (Antibacterial, Antifungals, Antivirals), Route of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年兽用感染疾病物市场价值为38.4亿美元，预计2024年将达到42.8亿美元，复合年增长率为11.97%，2030年将达到84.7亿美元，预计将达到1000万美元。

兽用感染疾病物市场包括用于预防、控制和治疗动物感染疾病的多种药物。这包括抗生素、抗病毒药物、抗霉菌药、抗寄生虫药等。维持牲畜健康和生产力、确保食品安全以及为伴同性动物提供最佳护理的需求推动了对兽用感染疾病的需求。这些产品应用于各种最终用途领域，包括畜牧场、兽医院、水产养殖和伴同性动物收容所。这一市场趋势受到动物疾病发病率上升、畜牧业产量增加以满足全球粮食需求以及宠物饲养趋势（尤其是在新兴经济体）的显着影响。

主要市场统计
基准年[2023] 38.4亿美元
预测年份 [2024] 42.8亿美元
预测年份 [2030] 84.7亿美元
复合年增长率（%） 11.97%

市场开拓机会源自于药物开发的进步，特别是频谱感染疾病和降低细菌抗药性的药物的开发。促进负责任地使用抗生素的监管变化也为益生菌和疫苗等替代疗法提供了成长途径。然而，该市场面临局限性，包括严格的监管要求、高昂的市场开拓成本以及对抗生素抗药性日益增长的担忧。这些挑战需要创新疗法的开发，以尽量减少对抗药性细菌的影响。

研究、开发和创新可以集中在提高药物疗效、开发快速诊断工具以减少抗生素滥用，以及探索传统抗生素的天然或合成替代品。最佳的创新领域是组合药物配方和改善治疗效果的新的给药机制。了解正在转向永续性并最大限度地减少环境影响的市场性质对于指导业务策略至关重要。

随着产业格局变得更加复杂，需要采取多方面的研发方法，强调与产业相关人员、学术界和监管机构的合作，以克服挑战并有效利用新机会。透过优先考虑精准医疗和综合农业，企业可以更好地符合市场需求和监管标准，为永续成长铺平道路。

市场动态：快速发展的兽用感染疾病物市场的关键市场洞察

供需的动态交互作用正在改变兽用感染疾病物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 动物保健意识不断增强
    • 通用感染疾病发生率上升
    • 由于人们对宠物健康的兴趣日益浓厚，越来越多的人收养伴同性动物
  • 市场限制因素
    • 兽医服务成本高
  • 市场机会
    • 各政府机构和动物协会的有利倡议
    • 扩大动物保健领域的研发活动
  • 市场挑战
    • 与假药相关的威胁

波特五力：驾驭兽用感染疾病物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解兽用感染疾病物市场的外部影响

外部宏观环境因素在塑造兽用感染疾病物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解兽用感染疾病市场竞争状况

对兽用感染疾病物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵兽用感染疾病市场供应商绩效评估

FPNV定位矩阵是评估兽用感染疾病物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘兽用感染疾病物市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对兽用感染疾病物市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高动物保健意识
      • 通用感染疾病发生率上升
      • 随着对宠物健康的担忧增加，宠物拥有量不断增加
    • 抑制因素
      • 兽医服务成本高
    • 机会
      • 各政府机构和动物协会的积极倡议
      • 扩大动物保健领域的研发活动
    • 任务
      • 与假药相关的威胁
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依动物类型分類的兽用感染疾病市场

  • 宠物
    • 猫
    • 狗
  • 家畜
    • 牛
    • 鱼
    • 家禽
    • 绵羊和山羊
    • 猪

第七章兽用感染疾病市场：依产品类型

  • 抗菌的
    • 头孢菌素
    • 大环内酯
    • 青霉素
    • 四环霉素
  • 抗真菌药物
  • 抗病毒药物

第八章 兽用感染疾病市场：依给药途径

  • 注射
  • 口服

第九章兽用感染疾病市场：依通路划分

  • 电子商务
  • 零售药房
  • 兽医诊所

第10章：美洲兽用感染疾病物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太兽用感染疾病市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲兽用感染疾病市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nutreco NV
  • Perrigo Company PLC
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-2214614768CF

The Veterinary Anti-infectives Market was valued at USD 3.84 billion in 2023, expected to reach USD 4.28 billion in 2024, and is projected to grow at a CAGR of 11.97%, to USD 8.47 billion by 2030.

The veterinary anti-infectives market encompasses a broad range of medications used to prevent, control, and treat infections in animals. This includes antibiotics, antivirals, antifungals, and antiparasitic agents. The necessity for veterinary anti-infectives is driven by the need to maintain the health and productivity of livestock, ensure food safety, and provide optimal care for companion animals. These products are applied across various end-use areas such as livestock farms, veterinary clinics, aquaculture, and companion animal shelters. Growth in this market is significantly influenced by the rising incidence of animal diseases, increasing livestock production to meet global food demand, and the expanding pet ownership trend, especially in emerging economies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.84 billion
Estimated Year [2024] USD 4.28 billion
Forecast Year [2030] USD 8.47 billion
CAGR (%) 11.97%

Opportunities in the market arise from advancements in drug development, particularly in creating broad-spectrum anti-infectives and those with reduced resistance potential. Regulatory changes promoting the responsible use of antibiotics also present growth avenues for alternative therapies such as probiotics and vaccines. However, the market does face limitations, including stringent regulatory requirements, high development costs, and the growing concern over antibiotic resistance. These challenges necessitate innovations in developing novel therapeutics with minimal resistance impact.

Research and innovation can focus on enhancing drug efficacy, developing rapid diagnostic tools to reduce misuse of antibiotics, and exploring natural or synthetic alternatives to traditional antimicrobials. The best areas for innovation could be in the formulation of combination drugs or new delivery mechanisms that improve treatment outcomes. Understanding the market's nature, which is shifting towards sustainability and minimal environmental impact, is vital for guiding business strategies.

The complex landscape of veterinary anti-infectives requires a multifaceted approach to research and development, with emphasis on collaboration between industry players, academia, and regulatory bodies to overcome challenges and harness emerging opportunities effectively. By prioritizing precision medicine and integrated farming practices, businesses can better align with market demands and regulatory criteria, paving the way for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Anti-infectives Market

The Veterinary Anti-infectives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness regarding animal healthcare
    • Rising incidence of zoonotic diseases
    • Increasing adoption of companion animals with rising concerns to pet wellbeing
  • Market Restraints
    • High cost of veterinary services
  • Market Opportunities
    • Favorable initiatives by various government agencies and animal associations
    • Growing R&D activities in the animal healthcare
  • Market Challenges
    • Threat associated with counterfeit medicines

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Anti-infectives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Anti-infectives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Anti-infectives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Anti-infectives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Anti-infectives Market

A detailed market share analysis in the Veterinary Anti-infectives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Anti-infectives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Anti-infectives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Anti-infectives Market

A strategic analysis of the Veterinary Anti-infectives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Anti-infectives Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Anti-infectives Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Animal Type, market is studied across Companion Animal and Livestock. The Companion Animal is further studied across Cat and Dog. The Livestock is further studied across Cattle, Fish, Poultry, Sheep & Goats, and Swine.
  • Based on Product Type, market is studied across Antibacterial, Antifungals, and Antivirals. The Antibacterial is further studied across Cephalosporins, Macrolides, Penicillin, and Tetracyclines.
  • Based on Route of Administration, market is studied across Injectables and Oral.
  • Based on Distribution Channel, market is studied across E-Commerce, Retail Pharmacies, and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness regarding animal healthcare
      • 5.1.1.2. Rising incidence of zoonotic diseases
      • 5.1.1.3. Increasing adoption of companion animals with rising concerns to pet wellbeing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary services
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable initiatives by various government agencies and animal associations
      • 5.1.3.2. Growing R&D activities in the animal healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. Threat associated with counterfeit medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Anti-infectives Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Companion Animal
    • 6.2.1. Cat
    • 6.2.2. Dog
  • 6.3. Livestock
    • 6.3.1. Cattle
    • 6.3.2. Fish
    • 6.3.3. Poultry
    • 6.3.4. Sheep & Goats
    • 6.3.5. Swine

7. Veterinary Anti-infectives Market, by Product Type

  • 7.1. Introduction
  • 7.2. Antibacterial
    • 7.2.1. Cephalosporins
    • 7.2.2. Macrolides
    • 7.2.3. Penicillin
    • 7.2.4. Tetracyclines
  • 7.3. Antifungals
  • 7.4. Antivirals

8. Veterinary Anti-infectives Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectables
  • 8.3. Oral

9. Veterinary Anti-infectives Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. E-Commerce
  • 9.3. Retail Pharmacies
  • 9.4. Veterinary Clinics

10. Americas Veterinary Anti-infectives Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Anti-infectives Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Anti-infectives Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago SA
  • 2. Boehringer Ingelheim International GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Elanco Animal Health Incorporated
  • 6. Evonik Industries AG
  • 7. Hester Biosciences Limited
  • 8. Huvepharma, Inc.
  • 9. Merck & Co., Inc.
  • 10. Neogen Corporation
  • 11. Nutreco N.V.
  • 12. Perrigo Company PLC
  • 13. Vetoquinol S.A.
  • 14. Virbac S.A.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY ANTI-INFECTIVES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY ANTI-INFECTIVES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY ANTI-INFECTIVES MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DOG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE